JLL Partners to acquire BioClinica and CoreLab Partners
BioClinica, a provider of clinical trial management solutions, has entered into a definitive agreement to be acquired by a holding company controlled by private equity firm JLL Partners.
Simultaneously, JLL Partners has reached a definitive agreement to acquire CoreLab Partners, a provider of medical imaging solutions and cardiac safety services based in Princeton, New Jersey.
Following the proposed acquisitions, BioClinica and CoreLab Partners will be merged to create a provider of medical imaging services and eClinical solutions for clinical trials. Ampersand Capital Partners, which is the majority owner of CoreLab Partners, will also be a significant investor in the combined company.
Mark L Weinstein, currently president and chief executive of BioClinica, will lead the combined company.
Dan Agroskin, managing director of JLL Partners, say: “We are excited about the tremendous promise of this business combination given the strong fundamentals of each company and the overall industry. We will conservatively capitalise the combined business and look forward to supporting its continued growth.”
- By Category
- News from other sites
- Special Reports